Topical NSAIDs are the safest first-line medication for arthritis pain in an 88-year-old female taking Eliquis
For this patient, I strongly recommend starting with topical NSAIDs (such as diclofenac gel) applied to the affected joints, avoiding oral NSAIDs entirely due to the significant bleeding risk when combined with apixaban.
Why Topical NSAIDs First
The 2019 ACR/Arthritis Foundation guideline 1 and NICE guidance 2 both recommend topical NSAIDs as a preferred option before oral NSAIDs, particularly for knee and hand osteoarthritis. This is especially critical in your patient because:
Eliquis (apixaban) significantly increases bleeding risk when combined with oral NSAIDs 3. The FDA label explicitly warns that "long-term (chronic) use of nonsteroidal anti-inflammatory drugs (NSAIDs)" increases bleeding risk in patients on apixaban, including risk of gastrointestinal bleeding, which can be life-threatening.
At 88 years old, she faces dramatically elevated risks from oral NSAIDs. Recent data shows patients >80 years have 10-fold higher risk of renal events and 7-fold higher risk of myocardial infarction compared to younger patients on NSAIDs 4.
Topical NSAIDs provide meaningful pain relief with minimal systemic absorption, avoiding the drug-drug interaction with Eliquis while maintaining efficacy for accessible joints.
The Acetaminophen Controversy
While older guidelines recommended acetaminophen (paracetamol) first 2, the 2019 ACR guideline 1 notes that acetaminophen is often ineffective as monotherapy, with patient panels reporting it provides inadequate relief for most individuals. However, it remains an option for short-term or episodic use when other medications are contraindicated. Given her age and anticoagulation, acetaminophen (maximum 3 grams daily in divided doses) can be used alongside topical NSAIDs if needed, with monitoring for hepatotoxicity.
If Topical NSAIDs Are Insufficient
Second-line option: Duloxetine 30-60 mg daily 1. This centrally-acting agent provides pain relief without bleeding risk and is conditionally recommended by the ACR for knee, hip, and hand osteoarthritis. It's particularly useful when topical therapy proves inadequate and avoids the anticoagulant interaction entirely.
Third-line option: Tramadol 1, though this carries risks of dependence and should be used at the lowest dose for the shortest duration. The ACR conditionally recommends tramadol over other opioids when alternatives have failed.
What to Absolutely Avoid
Oral NSAIDs (ibuprofen, naproxen, diclofenac) and COX-2 inhibitors (celecoxib): The combination with Eliquis creates unacceptable bleeding risk 3, 4. Even "safer" options like naproxen or celecoxib still increase bleeding when combined with anticoagulants.
Non-tramadol opioids: The ACR conditionally recommends against these 1 due to minimal long-term benefit and high risk of toxicity and dependence in elderly patients.
Critical Monitoring Points
- If acetaminophen is used regularly, monitor liver function tests
- Watch for any signs of bleeding (bruising, dark stools, prolonged bleeding from minor cuts) given her anticoagulation
- Consider intra-articular corticosteroid injections 2 for moderate-to-severe pain in specific joints—these provide localized relief without systemic drug interactions
The Algorithm
- Start: Topical NSAID (diclofenac gel) to affected joints 4 times daily
- Add if needed: Acetaminophen 650 mg three times daily (max 3 grams/day)
- If inadequate after 2-4 weeks: Add duloxetine 30 mg daily, titrate to 60 mg
- If still inadequate: Consider tramadol 25-50 mg as needed (lowest effective dose)
- For acute flares: Intra-articular corticosteroid injection to specific joint
Never use oral NSAIDs or COX-2 inhibitors in this patient on Eliquis—the bleeding risk outweighs any analgesic benefit.